Aster Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,780
Closed -$12.8K 1190
2025
Q4
$12.8K Buy
+1,780
New +$14.1K 0.01% 709
2025
Q2
Sell
-14,683
Closed -$219K 1417
2025
Q1
$219K Buy
+14,683
New +$226K 0.04% 467

Other funds holding OGN

Aster Capital Management's OGN Position: Q1 2026 in Review

Aster Capital Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 1,780 shares — an estimated $12.8K sold.

Aster Capital Management first reported a position in OGN in Q1 2025 and held it in 2 quarters. The position peaked at $219K in Q1 2025. 607 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Aster Capital Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 1,780 Organon & Co shares in Q1 2026, an estimated $12.8K.
  • Aster Capital Management first reported a position in Organon & Co in Q1 2025 and held it in 2 quarters.
  • Aster Capital Management's Organon & Co position peaked at $219K in Q1 2025.
  • 607 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.